|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,268 GBX | +0.16% |
|
+2.21% | +6.30% |
| Apr. 23 | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
| Apr. 23 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
EXCLUSIVE-SUSPECTED NORTH KOREAN HACKERS TARGETED COVID VACCINE MAKER ASTRAZENECA-SOURCES
| 1st Jan change | Capi. | |
|---|---|---|
| +6.30% | 215B | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B | |
| -4.99% | 146B |
ASTRAZENECA PLC 
